Global Dabigatran Market Growth (Status and Outlook) 2022-2028
- LP 4814623
- 88 Pages
- February 2022
- Pharmaceuticals
The United States Dabigatran market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dabigatran market, reaching US$ million by the year 2028. As for the Europe Dabigatran landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Dabigatran players cover Pfizer, Bayer Healthcare, GlaxoSmithKline, and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dabigatran market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Tablets
Capsule
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Deep Vein Thrombosis
Pulmonary Embolism
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Bayer Healthcare
GlaxoSmithKline
Boehringer Ingelheim
Aspen Holdings
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dabigatran Market Size 2017-2028
2.1.2 Dabigatran Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Dabigatran Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Others
2.3 Dabigatran Market Size by Type
2.3.1 Dabigatran Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Dabigatran Market Size Market Share by Type (2017-2022)
2.4 Dabigatran Segment by Application
2.4.1 Deep Vein Thrombosis
2.4.2 Pulmonary Embolism
2.4.3 Others
2.5 Dabigatran Market Size by Application
2.5.1 Dabigatran Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Dabigatran Market Size Market Share by Application (2017-2022)
3 Dabigatran Market Size by Player
3.1 Dabigatran Market Size Market Share by Players
3.1.1 Global Dabigatran Revenue by Players (2020-2022)
3.1.2 Global Dabigatran Revenue Market Share by Players (2020-2022)
3.2 Global Dabigatran Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Dabigatran by Regions
4.1 Dabigatran Market Size by Regions (2017-2022)
4.2 Americas Dabigatran Market Size Growth (2017-2022)
4.3 APAC Dabigatran Market Size Growth (2017-2022)
4.4 Europe Dabigatran Market Size Growth (2017-2022)
4.5 Middle East & Africa Dabigatran Market Size Growth (2017-2022)
5 Americas
5.1 Americas Dabigatran Market Size by Country (2017-2022)
5.2 Americas Dabigatran Market Size by Type (2017-2022)
5.3 Americas Dabigatran Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dabigatran Market Size by Region (2017-2022)
6.2 APAC Dabigatran Market Size by Type (2017-2022)
6.3 APAC Dabigatran Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dabigatran by Country (2017-2022)
7.2 Europe Dabigatran Market Size by Type (2017-2022)
7.3 Europe Dabigatran Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dabigatran by Region (2017-2022)
8.2 Middle East & Africa Dabigatran Market Size by Type (2017-2022)
8.3 Middle East & Africa Dabigatran Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Dabigatran Market Forecast
10.1 Global Dabigatran Forecast by Regions (2023-2028)
10.1.1 Global Dabigatran Forecast by Regions (2023-2028)
10.1.2 Americas Dabigatran Forecast
10.1.3 APAC Dabigatran Forecast
10.1.4 Europe Dabigatran Forecast
10.1.5 Middle East & Africa Dabigatran Forecast
10.2 Americas Dabigatran Forecast by Country (2023-2028)
10.2.1 United States Dabigatran Market Forecast
10.2.2 Canada Dabigatran Market Forecast
10.2.3 Mexico Dabigatran Market Forecast
10.2.4 Brazil Dabigatran Market Forecast
10.3 APAC Dabigatran Forecast by Region (2023-2028)
10.3.1 China Dabigatran Market Forecast
10.3.2 Japan Dabigatran Market Forecast
10.3.3 Korea Dabigatran Market Forecast
10.3.4 Southeast Asia Dabigatran Market Forecast
10.3.5 India Dabigatran Market Forecast
10.3.6 Australia Dabigatran Market Forecast
10.4 Europe Dabigatran Forecast by Country (2023-2028)
10.4.1 Germany Dabigatran Market Forecast
10.4.2 France Dabigatran Market Forecast
10.4.3 UK Dabigatran Market Forecast
10.4.4 Italy Dabigatran Market Forecast
10.4.5 Russia Dabigatran Market Forecast
10.5 Middle East & Africa Dabigatran Forecast by Region (2023-2028)
10.5.1 Egypt Dabigatran Market Forecast
10.5.2 South Africa Dabigatran Market Forecast
10.5.3 Israel Dabigatran Market Forecast
10.5.4 Turkey Dabigatran Market Forecast
10.5.5 GCC Countries Dabigatran Market Forecast
10.6 Global Dabigatran Forecast by Type (2023-2028)
10.7 Global Dabigatran Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Dabigatran Product Offered
11.1.3 Pfizer Dabigatran Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Information
11.2.2 Bayer Healthcare Dabigatran Product Offered
11.2.3 Bayer Healthcare Dabigatran Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bayer Healthcare Main Business Overview
11.2.5 Bayer Healthcare Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Dabigatran Product Offered
11.3.3 GlaxoSmithKline Dabigatran Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Dabigatran Product Offered
11.4.3 Boehringer Ingelheim Dabigatran Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Boehringer Ingelheim Main Business Overview
11.4.5 Boehringer Ingelheim Latest Developments
11.5 Aspen Holdings
11.5.1 Aspen Holdings Company Information
11.5.2 Aspen Holdings Dabigatran Product Offered
11.5.3 Aspen Holdings Dabigatran Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Aspen Holdings Main Business Overview
11.5.5 Aspen Holdings Latest Developments
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Information
11.6.2 Bristol-Myers Squibb Company Dabigatran Product Offered
11.6.3 Bristol-Myers Squibb Company Dabigatran Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bristol-Myers Squibb Company Main Business Overview
11.6.5 Bristol-Myers Squibb Company Latest Developments
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Information
11.7.2 Teva Pharmaceutical Industries Dabigatran Product Offered
11.7.3 Teva Pharmaceutical Industries Dabigatran Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Teva Pharmaceutical Industries Main Business Overview
11.7.5 Teva Pharmaceutical Industries Latest Developments
12 Research Findings and Conclusion
Table 1. Dabigatran Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Tablets
Table 3. Major Players of Capsule
Table 4. Major Players of Others
Table 5. Dabigatran Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Dabigatran Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Dabigatran Market Size Market Share by Type (2017-2022)
Table 8. Dabigatran Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Dabigatran Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Dabigatran Market Size Market Share by Application (2017-2022)
Table 11. Global Dabigatran Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Dabigatran Revenue Market Share by Player (2020-2022)
Table 13. Dabigatran Key Players Head office and Products Offered
Table 14. Dabigatran Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Dabigatran Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Dabigatran Market Size Market Share by Regions (2017-2022)
Table 19. Americas Dabigatran Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Dabigatran Market Size Market Share by Country (2017-2022)
Table 21. Americas Dabigatran Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Dabigatran Market Size Market Share by Type (2017-2022)
Table 23. Americas Dabigatran Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Dabigatran Market Size Market Share by Application (2017-2022)
Table 25. APAC Dabigatran Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Dabigatran Market Size Market Share by Region (2017-2022)
Table 27. APAC Dabigatran Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Dabigatran Market Size Market Share by Type (2017-2022)
Table 29. APAC Dabigatran Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Dabigatran Market Size Market Share by Application (2017-2022)
Table 31. Europe Dabigatran Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Dabigatran Market Size Market Share by Country (2017-2022)
Table 33. Europe Dabigatran Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Dabigatran Market Size Market Share by Type (2017-2022)
Table 35. Europe Dabigatran Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Dabigatran Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Dabigatran Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Dabigatran Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Dabigatran Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Dabigatran Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Dabigatran Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Dabigatran Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Dabigatran
Table 44. Key Market Challenges & Risks of Dabigatran
Table 45. Key Industry Trends of Dabigatran
Table 46. Global Dabigatran Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Dabigatran Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Dabigatran Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Dabigatran Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Dabigatran Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Dabigatran Market Size Market Share Forecast by Application (2023-2028)
Table 52. Pfizer Details, Company Type, Dabigatran Area Served and Its Competitors
Table 53. Pfizer Dabigatran Product Offered
Table 54. Pfizer Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Bayer Healthcare Details, Company Type, Dabigatran Area Served and Its Competitors
Table 58. Bayer Healthcare Dabigatran Product Offered
Table 59. Bayer Healthcare Main Business
Table 60. Bayer Healthcare Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bayer Healthcare Latest Developments
Table 62. GlaxoSmithKline Details, Company Type, Dabigatran Area Served and Its Competitors
Table 63. GlaxoSmithKline Dabigatran Product Offered
Table 64. GlaxoSmithKline Main Business
Table 65. GlaxoSmithKline Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. GlaxoSmithKline Latest Developments
Table 67. Boehringer Ingelheim Details, Company Type, Dabigatran Area Served and Its Competitors
Table 68. Boehringer Ingelheim Dabigatran Product Offered
Table 69. Boehringer Ingelheim Main Business
Table 70. Boehringer Ingelheim Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Boehringer Ingelheim Latest Developments
Table 72. Aspen Holdings Details, Company Type, Dabigatran Area Served and Its Competitors
Table 73. Aspen Holdings Dabigatran Product Offered
Table 74. Aspen Holdings Main Business
Table 75. Aspen Holdings Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Aspen Holdings Latest Developments
Table 77. Bristol-Myers Squibb Company Details, Company Type, Dabigatran Area Served and Its Competitors
Table 78. Bristol-Myers Squibb Company Dabigatran Product Offered
Table 79. Bristol-Myers Squibb Company Main Business
Table 80. Bristol-Myers Squibb Company Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Bristol-Myers Squibb Company Latest Developments
Table 82. Teva Pharmaceutical Industries Details, Company Type, Dabigatran Area Served and Its Competitors
Table 83. Teva Pharmaceutical Industries Dabigatran Product Offered
Table 84. Teva Pharmaceutical Industries Main Business
Table 85. Teva Pharmaceutical Industries Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Teva Pharmaceutical Industries Latest Developments
List of Figures
Figure 1. Dabigatran Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Dabigatran Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Dabigatran Market Size Market Share by Type in 2021
Figure 7. Dabigatran in Deep Vein Thrombosis
Figure 8. Global Dabigatran Market: Deep Vein Thrombosis (2017-2022) & ($ Millions)
Figure 9. Dabigatran in Pulmonary Embolism
Figure 10. Global Dabigatran Market: Pulmonary Embolism (2017-2022) & ($ Millions)
Figure 11. Dabigatran in Others
Figure 12. Global Dabigatran Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Dabigatran Market Size Market Share by Application in 2021
Figure 14. Global Dabigatran Revenue Market Share by Player in 2021
Figure 15. Global Dabigatran Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Dabigatran Market Size 2017-2022 ($ Millions)
Figure 17. APAC Dabigatran Market Size 2017-2022 ($ Millions)
Figure 18. Europe Dabigatran Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Dabigatran Market Size 2017-2022 ($ Millions)
Figure 20. Americas Dabigatran Value Market Share by Country in 2021
Figure 21. Americas Dabigatran Consumption Market Share by Type in 2021
Figure 22. Americas Dabigatran Market Size Market Share by Application in 2021
Figure 23. United States Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Dabigatran Market Size Market Share by Region in 2021
Figure 28. APAC Dabigatran Market Size Market Share by Application in 2021
Figure 29. China Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Dabigatran Market Size Market Share by Country in 2021
Figure 36. Europe Dabigatran Market Size Market Share by Type in 2021
Figure 37. Europe Dabigatran Market Size Market Share by Application in 2021
Figure 38. Germany Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Dabigatran Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Dabigatran Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Dabigatran Market Size Market Share by Application in 2021
Figure 46. Egypt Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Dabigatran Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Dabigatran Market Size 2023-2028 ($ Millions)
Figure 52. APAC Dabigatran Market Size 2023-2028 ($ Millions)
Figure 53. Europe Dabigatran Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Dabigatran Market Size 2023-2028 ($ Millions)
Figure 55. United States Dabigatran Market Size 2023-2028 ($ Millions)
Figure 56. Canada Dabigatran Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Dabigatran Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Dabigatran Market Size 2023-2028 ($ Millions)
Figure 59. China Dabigatran Market Size 2023-2028 ($ Millions)
Figure 60. Japan Dabigatran Market Size 2023-2028 ($ Millions)
Figure 61. Korea Dabigatran Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Dabigatran Market Size 2023-2028 ($ Millions)
Figure 63. India Dabigatran Market Size 2023-2028 ($ Millions)
Figure 64. Australia Dabigatran Market Size 2023-2028 ($ Millions)
Figure 65. Germany Dabigatran Market Size 2023-2028 ($ Millions)
Figure 66. France Dabigatran Market Size 2023-2028 ($ Millions)
Figure 67. UK Dabigatran Market Size 2023-2028 ($ Millions)
Figure 68. Italy Dabigatran Market Size 2023-2028 ($ Millions)
Figure 69. Russia Dabigatran Market Size 2023-2028 ($ Millions)
Figure 70. Spain Dabigatran Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Dabigatran Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Dabigatran Market Size 2023-2028 ($ Millions)
Figure 73. Israel Dabigatran Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Dabigatran Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Dabigatran Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
